BackgroundWhile factors that drive early mortality among people living with HIV (PLWH) initiating antiretroviral therapy (ART) in sub-Saharan Africa (SSA) have been described, less is known about the predictors of long-term mortality for those with ART experience.MethodsPLWH and on ART attending two HIV treatment clinics in Moshi, Tanzania were enrolled from 2008 through 2009 and followed for 3.5 years. Demographic, psychosocial, and clinical information were collected at enrollment. Plasma HIV RNA measurements were collected annually. Cause of death was adjudicated by two independent reviewers based on verbal autopsy information and medical records. Bivariable and multivariable analyses were conducted using Cox proportional hazard models t...
International audienceBACKGROUND: Mortality in HIV-infected patients who have access to highly activ...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
Background: Mortality in HIV-infected patients who have access to highly active antiretroviral thera...
BACKGROUND: Studies of antiretroviral therapy (ART) programs in Africa have shown high initial morta...
Background: Studies of antiretroviral therapy (ART) programs in Africa have shown high initial morta...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in to ART are in...
Abstract Objective: To identify predictors of mortality in patients initiating antiretroviral therap...
IntroductionDespite increased treatment availability, HIV-infected individuals continue to start ant...
Abstract Background Studies indicate that there is high early mortality among patients starting anti...
Knowledge of mortality trends and predictors among HIV-positive patients in the era of highly active...
Background: Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in t...
BACKGROUND: Mortality in HIV-infected patients who have access to highly active antiretroviral thera...
Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has...
BackgroundWe report trends in mortality patterns and causes among HIV positive patients, who initiat...
International audienceBACKGROUND: Mortality in HIV-infected patients who have access to highly activ...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
Background: Mortality in HIV-infected patients who have access to highly active antiretroviral thera...
BACKGROUND: Studies of antiretroviral therapy (ART) programs in Africa have shown high initial morta...
Background: Studies of antiretroviral therapy (ART) programs in Africa have shown high initial morta...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in to ART are in...
Abstract Objective: To identify predictors of mortality in patients initiating antiretroviral therap...
IntroductionDespite increased treatment availability, HIV-infected individuals continue to start ant...
Abstract Background Studies indicate that there is high early mortality among patients starting anti...
Knowledge of mortality trends and predictors among HIV-positive patients in the era of highly active...
Background: Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in t...
BACKGROUND: Mortality in HIV-infected patients who have access to highly active antiretroviral thera...
Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has...
BackgroundWe report trends in mortality patterns and causes among HIV positive patients, who initiat...
International audienceBACKGROUND: Mortality in HIV-infected patients who have access to highly activ...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
Background: Mortality in HIV-infected patients who have access to highly active antiretroviral thera...